Stockscreener 앱 받기
1.59
1.24%
-0.02
시간 외 거래:
1.64
0.05
+3.14%
전일 마감가:
$1.61
열려 있는:
$1.605
하루 거래량:
54,113
Relative Volume:
0.22
시가총액:
$5.27M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.00%
1개월 성능:
-8.09%
6개월 성능:
-79.05%
1년 성능:
-90.49%
1일 변동 폭
$1.58
$1.67
1주일 범위
$1.50
$1.6794
52주 변동 폭
$1.43
$23.10
Metavia Inc Stock (MTVA) Company Profile
명칭
Metavia Inc
전화
(857) 702-9600
주소
545 CONCORD AVENUE, CAMBRIDGE
Compare MTVA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MTVA
Metavia Inc
|
1.59 | 5.34M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Metavia Inc Stock (MTVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 재개 | H.C. Wainwright | Buy |
| 2024-12-30 | 개시 | H.C. Wainwright | Buy |
Metavia Inc 주식(MTVA)의 최신 뉴스
MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum - PR Newswire
Buyout Rumor: Will MetaVia Inc outperform its industry peersMarket Sentiment Summary & Target Return Focused Picks - baoquankhu1.vn
Growth Value: How does FCCO compare to its peersJuly 2025 Review & Verified Trade Idea Suggestions - baoquankhu1.vn
MetaVia: DA-1726 and vanoglipel advance in clinical trials, with key data and partnerships expected this year - TradingView
MetaVia: Promising early results for obesity and MASH drugs set up major 2024 data and partnership catalysts - TradingView
Dow Update: Should I invest in MetaVia Inc before earningsJuly 2025 Closing Moves & Accurate Entry/Exit Alerts - baoquankhu1.vn
MTVA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Investment Recap: Is MetaVia Inc currently under institutional pressureTrade Signal Summary & Daily Entry Point Trade Alerts - baoquankhu1.vn
Hedge Fund Bets: Why is CCNE stock going downJuly 2025 Big Picture & Community Verified Trade Signals - baoquankhu1.vn
Chart Watch: What are CIOPRAs recent SEC filings showingJuly 2025 Market Mood & Community Trade Idea Sharing Platform - baoquankhu1.vn
RenovoRx (NASDAQ:RNXT) vs. MetaVia (NASDAQ:MTVA) Head-To-Head Survey - Defense World
Aug Ideas: Should I invest in MetaVia Inc before earningsTrade Volume Summary & High Conviction Investment Ideas - baoquankhu1.vn
Trade Recap: Is now the right time to enter MetaVia IncJuly 2025 Setups & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Emerging Growth Conference - PR Newswire
Can MetaVia Inc. stock outperform in a bear marketTreasury Yields & Proven Capital Preservation Methods - mfd.ru
What is the target price for MetaVia Inc. stockEarnings Summary Report & Risk Controlled Swing Alerts - mfd.ru
How MetaVia Inc. stock performs in stagflationTrade Risk Report & Fast Entry and Exit Trade Plans - mfd.ru
MetaVia secures patent protection for obesity treatment through 2041 - Investing.com India
Metavia builds comprehensive global patent protection for DA-1726, securing exclusive rights to novel obesity and metabolic therapy - marketscreener.com
Can MetaVia Inc. continue delivering strong returnsMarket Movers & Entry Point Confirmation Signals - mfd.ru
MetaVia Builds Comprehensive Global Patent Protection for DA-1726, Securing Exclusive Rights to Novel Obesity and Metabolic Therapy Through 2041 - PR Newswire
Will MetaVia Inc. outperform its industry peers2025 Historical Comparison & Fast Entry and Exit Trade Plans - mfd.ru
Will MetaVia Inc. stock go up in YEAROil Prices & Real-Time Volume Surge Alerts - mfd.ru
Earnings Recap: What analysts say about MetaVia Inc. stockWeekly Investment Report & Fast Gaining Stock Strategy Reports - mfd.ru
MetaVia (MTVA) Stock Price, News & Analysis - MarketBeat
Aug Drivers: Does MetaVia Inc outperform in volatile markets2025 Big Picture & Fast Momentum Entry Tips - baoquankhu1.vn
Technical Analysis: Is now the right time to enter MetaVia IncJuly 2025 Earnings & Real-Time Buy Signal Alerts - baoquankhu1.vn
AI modeling confirms therapeutic targets for MetaVia’s vanoglipel By Investing.com - Investing.com Australia
Metavia Inc announces positive AI-modeling results from ongoing SyntekaBio collaboration, confirming key therapeutic targets for Vanoglipel - marketscreener.com
AI modeling confirms therapeutic targets for MetaVia’s vanoglipel - Investing.com
Metavia IncAnnounces Positive Ai-Modeling Results From Ongoing Syntekabio Collaboration, Confirming Key Therapeutic Targets For Vanoglipel - TradingView
MetaVia Announces Positive AI-Modeling Results from its Ongoing Syntekabio Collaboration, Confirming Key Therapeutic Targets for Vanoglipel - ChartMill
Bear Alert: Is REVBW a potential multi baggerWall Street Watch & Momentum Based Trading Signals - baoquankhu1.vn
Breakout Watch: Is MetaVia Inc in a consolidation phase2025 Trading Recap & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Aug EndMonth: How correlated is RNAC to the S P500July 2025 Weekly Recap & Daily Stock Trend Reports - baoquankhu1.vn
MetaVia Updates 2025 Executive Discretionary Bonus Disclosure - TipRanks
Gainers Report: What is the next catalyst for MetaVia IncWatch List & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Aug Selloffs: Will MetaVia Inc benefit from seasonalityWeekly Stock Report & Weekly High Momentum Picks - baoquankhu1.vn
Market Outlook: What is the PEG ratio of MetaVia Inc2025 Short Interest & Community Verified Watchlist Alerts - baoquankhu1.vn
Aug PreEarnings: What are analysts’ price targets for SLND.WS2025 Trading Volume Trends & Fast Gain Swing Alerts - baoquankhu1.vn
Aug Decliners: Can MetaVia Inc continue delivering strong returns2025 Risk Factors & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
MTVA Stock Price, Forecast & Analysis | METAVIA INC (NASDAQ:MTVA) - Chartmill
MTVA: Positive Results for 48 mg Cohort in Phase 1b Trial of DA-1726… - Yahoo Finance
Trade Report: Can MetaVia Inc stock outperform in a bear marketJuly 2025 Rallies & Weekly Market Pulse Alerts - baoquankhu1.vn
What Does the Market Think About MetaVia Inc? - Sahm
MetaVia (NASDAQ:MTVA) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
Aug Reactions: Is SWKH impacted by rising rates2025 Support & Resistance & Momentum Based Trading Ideas - baoquankhu1.vn
Aug Update: Does MetaVia Inc have strong fundamentalsPortfolio Gains Report & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
MetaVia closes $9.3 million public offering with full exercise of option - Investing.com Nigeria
MetaVia prices $8.1M underwritten public offering - MSN
MetaVia Completes Public Offering to Advance Obesity Drug - TipRanks
Metavia Inc (MTVA) 재무 분석
Metavia Inc (MTVA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
3.69%
0.68%
자본화:
|
볼륨(24시간):